SANUWAVE Health, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SANUWAVE Health, Inc. (SNWV) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $619.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-06
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $619.00K, a 43.95% increase year-over-year.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $430.00K.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $248.57K, a 47.78% decline from fiscal 2019.
- SANUWAVE Health, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $476.03K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $619.00K 10-Q · filed 2026-08-06 | $619.00K derived: sum of 3 quarters · filed 2026-08-06 | $619.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $619.00K 10-Q · filed 2026-05-12 | $619.00K derived: sum of 2 quarters · filed 2026-05-12 | $619.00K derived: sum of 3 quarters · filed 2026-05-12 | $619.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-24 | $600.00K 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $430.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $430.00K 10-Q · filed 2025-11-06 | $430.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $430.00K 10-Q · filed 2026-08-06 | $430.00K derived: sum of 3 quarters · filed 2026-08-06 | $430.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $430.00K 10-Q · filed 2026-05-12 | $430.00K derived: sum of 2 quarters · filed 2026-05-12 | $430.00K derived: sum of 3 quarters · filed 2026-05-12 | $430.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | ||||
| 2020-12-31 | $248.57K 10-K · filed 2021-10-21 | ||||
| 2019-12-31 | $476.03K 10-K · filed 2021-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |